Skip to main content
OpenTrials
Completed

NCT Number: NCT04737733

Effects of a Dementia-friendly Program

Frail older persons with cognitive impairment are at special risk of experiencing delirium during acute hospitalisation. The purpose of this study was to investigate whether a dementia-friendly hospital program contributes to improved detection and management of patients with cognitive impairment and delirium.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Delirium Brain Diseases Central Nervous System Diseases Cognition Disorders Cognitive Dysfunction Cognitive Impairment Confusion Dementia Mental Disorders Nervous System Diseases Neurobehavioral Manifestations Neurocognitive Disorders Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

75 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University hospital, Akershus

Lørenskog, 1478, Norway

About this study

Study design This study, has a non-equivalent control group design and a historical control Group. The Control group received usual care and the experimental group received usual care plus the dementia-friendly program.

One Group received care after implementing the dementia-friendly hospital program. The study is performed at two medical wards at a large acute-care hospital in Norway. A medical pulmonary ward and a cardiac ward participated.

Data Collection:

Demographic data included age, gender, place of residence (home, adapted housing, institution), and family/relative network, and were obtained upon admission to the study.

Medical data included cause of admission, active medical diagnoses, medications and medical treatment, and were obtained both at admission and from their electronic medical records after discharge.

Cognitive Impairment and delirium were assessed with two different screening tools: the Four Assessment Test (4AT) and the Confusion Assessment Method (CAM).

For all patients with a positive 4AT (≥1) or identified cognitive impairment during their hospital stays, a thorough review of the patient's journal was conducted upon discharge to record if, in case of yes, which type of preventive or treatment measures according to the dementia-friendly program, the patients had received during their stays.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients ≥75 years
  • acute admission to the cardiac or pulmonary wards.
  • Patient who has given informed written consent, or proxy consent from relatives for patients who lacked cognitive capacity.

Exclusion criteria

  • Readmitted patients enrolled in a previous hospital stay.
  • Patients who do not have sufficient verbal function or hearing to communicate
  • Patients in a coma or too ill to participate
  • Patients who are isolated
  • Patients who do not wish to participate or relatives who do not want the patient to participate, in the cases where the patient lacked cognitive capacity to consent.

Treatment and study plan

The dementia friendly program

Other

Implementation of a systematic screening and risk modification and management plan, to identify and enhance the management of patients with cognitive impairment and risk of delirium.

Primary outcomes

  1. Detection of patients with cognitive impairment

    Time frame: During the stay at the participating wards, assessed from the electronical medical record within 6 months after discharge

    Proportion of patients identified with cognitive impairment during the hospital stay, documented in the electronic Medical record. Difference between the control group and the intervention group. Patients were assessed with The Four Assessment Test at admission and during the stay at the participating wards. Furthermore, documentation of cognitive impairment in the electronic medical journal during the stay were assessed after discharge.

  2. Management of patients with cognitive impairment and delirium

    Time frame: During the stay at the participating wards, assessed from the electronical medical record within 6 months after discharge

    Proportion of patients identified with cognitive impairment, delirium or at risk of delirium who has documented interventions to prevent and/or treat delirium, according to the implemented dementia-friendly program.Differences between the control group and the intervention group.

Secondary outcomes

  1. Screening within 24 hours

    Time frame: Within 24 hours after admission to the ward

    Proportion of patients screened with The Four Assessment Test within 24 after hours after admission to the ward. Differences between the control group and the intervention group.

  2. Use of antipsychotics, hypnotics and sedatives

    Time frame: During the stay at the participating wards, assessed from the electronical medical record within 6 months after discharge

    Proportion of patients with cognitive impairment given doses of antipsychotics, hypnotics and sedatives during the stay at the participating wards. Differences between the control group and the intervention group. Given doses of antipsychotics, hypnotics and sedatives during the stay at the participating wards registered in the electronic medical journal, were assessed after discharge.

  3. Use of medications not recommended for the patient group

    Time frame: During the stay at the participating wards, assessed from the electronical medical record within 6 months after discharge

    Proportion of patients with cognitive impairment who uses medications which are not recommended for the patient group. Differences between the control group and the intervention group.

  4. Departure to rehabilitation or nursing home

    Time frame: Assessed from the electronical medical record, within 6 month after discharge

    Proportion of patients with departure to rehabilitation or nursing home. Departure to care level were assessed from the electronic medical journal after discharge.Differences between the control group and the intervention group.

  5. Length of hospital stay

    Time frame: Assessed from the electronical medical record, within 6 month after discharge

    Mean number of days at the hospital stay.Length of hospital stay were collected from the electronic medical journal after discharge.Differences between the control group and the intervention group.

  6. Delirium

    Time frame: Assessed from the electronical medical record, within 6 month after discharge

    Proportion of patients diagnosed with delirium. Delirium diagnosis documented during the stay at the participating wards were collected from the electronical medical record after discharge. Differences between the control group and the intervention group.

  7. 30-day readmission to the hospital

    Time frame: Readmissions to the hospital were assessed from the electronical medical record 30 days after discharge.

    Proportion of patients who are readmitted to the hospital within 30 days after discharge from the hospital. Differences between the control group and the intervention group.

  8. 30-day mortality

    Time frame: Mortality were assessed from the electronical medical record 30 days after discharge.

    Proportion of mortality in the patient group within 30 days after discharge from the hospital. Differences between the control group and the intervention group.

Sponsors and collaborators

Lead sponsor

University Hospital, Akershus

Other

Registry information

Official study title

Effects of a Dementia-friendly Program on Detection and Management of Patients With Cognitive Impairment and Delirium in Acute-care Hospital Units: a Non-equivalent Control Group Design

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Feb 4, 2021
Registry last updated
Feb 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.